TCL Archive House Preserves Funds For Space Station; Cancer Societies Reiterate Support For $170 Million Increase For NCI August 7, 1992
TCL Archive In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced August 3, 1990
TCL Archive In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay March 28, 1980
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
